{"id":1384,"date":"2009-12-16T09:42:21","date_gmt":"2009-12-16T14:42:21","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/fda-advisers-recommend-expanding-crestor-to-patients-without-high-cholesterol\/"},"modified":"2011-07-19T17:45:06","modified_gmt":"2011-07-19T21:45:06","slug":"fda-advisers-recommend-expanding-crestor-to-patients-without-high-cholesterol","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2009\/12\/16\/fda-advisers-recommend-expanding-crestor-to-patients-without-high-cholesterol\/","title":{"rendered":"FDA Advisers Recommend Expanding Crestor to Patients Without High Cholesterol"},"content":{"rendered":"<p>An FDA advisory panel voted 12 to 4 on Tuesday to expand the use of rosuvastatin (Crestor) to patients with normal cholesterol levels and no history of cardiac disease, according to the <a href=\"http:\/\/www.google.com\/hostednews\/ap\/article\/ALeqM5jK6EmpbL8swxcfV5tmu4EL4YfU0AD9CK0S1O0\">Associated Press<\/a>.<\/p>\n<p>The panel&#8217;s recommendation was based on last year&#8217;s <a href=\"http:\/\/content.nejm.org\/cgi\/content\/full\/NEJMoa0807646\">JUPITER trial<\/a>, in which rosuvastatin cut cardiovascular risk in patients with normal LDL cholesterol but high C-reactive protein levels.<\/p>\n<p>The manufacturer said it &#8220;would focus on marketing the drug to patients with health issues that put them at increased risk of heart problems, such as a smoking habit or family history of hypertension,&#8221; the AP reports.<\/p>\n<p>The FDA is expected to make its decision in early 2010.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An FDA advisory panel voted 12 to 4 on Tuesday to expand the use of rosuvastatin (Crestor) to patients with normal cholesterol levels and no history of cardiac disease, according to the Associated Press. The panel&#8217;s recommendation was based on last year&#8217;s JUPITER trial, in which rosuvastatin cut cardiovascular risk in patients with normal LDL [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1384","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1384"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1384\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}